|
2012 -- S 2154 | |
|
======= | |
|
LC00395 | |
|
======= | |
|
STATE OF RHODE ISLAND | |
|
| |
|
IN GENERAL ASSEMBLY | |
|
| |
|
JANUARY SESSION, A.D. 2012 | |
|
| |
|
____________ | |
|
| |
|
A N A C T | |
|
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT | |
|
|
      |
|
|
      |
|
     Introduced By: Senators Tassoni, Doyle, DiPalma, Cote, and DeVall | |
|
     Date Introduced: January 18, 2012 | |
|
     Referred To: Senate Judiciary | |
|
It is enacted by the General Assembly as follows: | |
|
1-1 |
     SECTION 1. Section 21-28-2.0.8 of the General Laws in Chapter 21-28 entitled |
|
1-2 |
"Uniform Controlled Substances Act" is hereby amended to read as follows: |
|
1-3 |
     21-28-2.08. Contents of schedules. -- Schedule I |
|
1-4 |
      (a) Schedule I shall consist of the drugs and other substances, by whatever official name, |
|
1-5 |
common or usual name, chemical name, or brand name designated, listed in this section. |
|
1-6 |
      (b) Opiates. - Unless specifically excepted or unless listed in another schedule, any of |
|
1-7 |
the following opiates, including its isomers, esters, ethers, salts, and salts of isomers, esters, and |
|
1-8 |
ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the |
|
1-9 |
specific chemical designation: |
|
1-10 |
      (1) Acetylmethadol |
|
1-11 |
      (2) Allylprodine |
|
1-12 |
      (3) Alphacetylmethadol |
|
1-13 |
      (4) Alphameprodine |
|
1-14 |
      (5) Alphamethadol |
|
1-15 |
      (6) Benzethidine |
|
1-16 |
      (7) Betacetylmethadol |
|
1-17 |
      (8) Betameprodine |
|
1-18 |
      (9) Betamethadol |
|
1-19 |
      (10) Betaprodine |
|
2-20 |
      (11) Clonitazene |
|
2-21 |
      (12) Dextromoramide |
|
2-22 |
      (13) Difenoxin |
|
2-23 |
      (14) Diampromide |
|
2-24 |
      (15) Diethylthiambutene |
|
2-25 |
      (16) Dimenoxadol |
|
2-26 |
      (17) Dimepheptanol |
|
2-27 |
      (18) Dimethylthiambutene |
|
2-28 |
      (19) Dioxaphetyl butyrate |
|
2-29 |
      (20) Dipipanone |
|
2-30 |
      (21) Ethylmethylthiambutene |
|
2-31 |
      (22) Etonitazene |
|
2-32 |
      (23) Extoxerdine |
|
2-33 |
      (24) Furethidine |
|
2-34 |
      (25) Hydroxypethidine |
|
2-35 |
      (26) Ketobemidone |
|
2-36 |
      (27) Levomoramide |
|
2-37 |
      (28) Levophenacylmorphan |
|
2-38 |
      (29) Morpheridine |
|
2-39 |
      (30) Noracymethadol |
|
2-40 |
      (31) Norlevorphanol |
|
2-41 |
      (32) Normethadone |
|
2-42 |
      (33) Norpipanone |
|
2-43 |
      (34) Phenadoxone |
|
2-44 |
      (35) Phenampromide |
|
2-45 |
      (36) Phenomorphan |
|
2-46 |
      (37) Phenoperidine |
|
2-47 |
      (38) Piritramide |
|
2-48 |
      (39) Proheptazine |
|
2-49 |
      (40) Properidine |
|
2-50 |
      (41) Propiram |
|
2-51 |
      (42) Racemoramide |
|
2-52 |
      (43) Trimeperidone |
|
2-53 |
      (44) Tilidine |
|
3-54 |
      (45) Alpha-methylfentanyl |
|
3-55 |
      (46) Beta-hydroxy-3-methylfentanyl other names: |
|
3-56 |
      N-[1-(2hydroxy-2-phenethyl)-3-methyl-4piperidingyl] Nphenylpropanamide |
|
3-57 |
      (c) Opium Derivatives. - Unless specifically excepted or unless listed in another |
|
3-58 |
schedule, any of the following opium derivatives, its salts, isomers, and salts of isomers whenever |
|
3-59 |
the existence of the salts, isomers, and salts of isomers is possible within the specific chemical |
|
3-60 |
designation: |
|
3-61 |
      (1) Acetorphine |
|
3-62 |
      (2) Acetyldihydrocodeine |
|
3-63 |
      (3) Benzylmorphine |
|
3-64 |
      (4) Codeine methylbromide |
|
3-65 |
      (5) Codeine-N-Oxide |
|
3-66 |
      (6) Cyprenorphine |
|
3-67 |
      (7) Desomorphine |
|
3-68 |
      (8) Dihydromorphine |
|
3-69 |
      (9) Etorphine (Except hydrochloride salt) |
|
3-70 |
      (10) Heroin |
|
3-71 |
      (11) Hydromorphinol |
|
3-72 |
      (12) Methyldesorphine |
|
3-73 |
      (13) Methylihydromorphine |
|
3-74 |
      (14) Morphine methylbromide |
|
3-75 |
      (15) Morphine methylsulfonate |
|
3-76 |
      (16) Morphine-N-Oxide |
|
3-77 |
      (17) Myrophine |
|
3-78 |
      (18) Nococodeine |
|
3-79 |
      (19) Nicomorphine |
|
3-80 |
      (20) Normorphine |
|
3-81 |
      (21) Pholcodine |
|
3-82 |
      (22) Thebacon |
|
3-83 |
      (23) Drotebanol |
|
3-84 |
      (d) Hallucinogenic Substances. - Unless specifically excepted or unless listed in another |
|
3-85 |
schedule, any material, compound, mixture, or preparation, which contains any quantity of the |
|
3-86 |
following hallucinogenic substances, or which contains any of its salts, isomers, and salts of |
|
3-87 |
isomers whenever the existence of the salts, isomers, and salts of isomers is possible within the |
|
3-88 |
specific chemical designation (for purposes of this subsection only, the term "isomer" includes |
|
4-1 |
the optical, position, and geometric isomers): |
|
4-2 |
      (1) 3, 4-methylenedioxy amphetamine |
|
4-3 |
      (2) 5-methoxy-3, 4-methylenedioxy amphetamine |
|
4-4 |
      (3) 3, 4, 5-trimethoxy amphetamine |
|
4-5 |
      (4) Bufotenine |
|
4-6 |
      (5) Diethyltryptamine |
|
4-7 |
      (6) Dimethyltryptamine |
|
4-8 |
      (7) 4-methyl 2, 5-dimethoxyamphetamine |
|
4-9 |
      (8) Ibogaine |
|
4-10 |
      (9) Lysergic acid diethylamide |
|
4-11 |
      (10) Marihuana |
|
4-12 |
      (11) Mescaline |
|
4-13 |
      (12) Peyote. Meaning all parts of the plant presently classified botanically as |
|
4-14 |
Lophophora Williamsii Lemair whether growing or not; the seeds of the plant; any extract from |
|
4-15 |
any part of the plant; and any compound, manufacture, salt, derivative, mixture, or preparation of |
|
4-16 |
the plant, its seeds or extracts. |
|
4-17 |
      (13) N-ethyl-3-piperidyl benzilate |
|
4-18 |
      (14) N-methyl-3-piperidyl benzilate |
|
4-19 |
      (15) Psilocybin |
|
4-20 |
      (16) Psilocyn |
|
4-21 |
      (17) Tetrahydrocannabinols. Synthetic equivalents of the substances contained in the |
|
4-22 |
plant, or in the resinous extractives of Cannabis, sp. and/or synthetic substances, derivatives, and |
|
4-23 |
their isomers with similar chemical structure and pharmacological activity such as the following: |
|
4-24 |
delta 1 cis or trans tetrahydrocannabinol, and their optical isomers. Delta 6 cis or trans |
|
4-25 |
tetrahydrocannabinol and their optical isomers. Delta 3, 4 cis or trans tetrahydrocannabinol and |
|
4-26 |
its optical isomer. (Since nomenclature of these substances is not internationally standardized, |
|
4-27 |
compounds of these structures, regardless of numerical designation of atomic positions covered). |
|
4-28 |
     (18) Thiophene analog of phencyclidine.1-(1-(2 thienyl) cyclo-hexyl) pipiridine:2- |
|
4-29 |
Thienylanalogofphencyclidine:TPCP |
|
4-30 |
     (19) 2,5dimethoxyamphetamine |
|
4-31 |
     (20) 4-romo-2,5-dimethoxyamphetamine,4-bromo-2,5-dimethoxy-alpha- |
|
4-32 |
methylphenethyamine:4-bromo-2,5-DMA |
|
4-33 |
     (21) 4-methoxyamphetamine-4-methoxy-alpha-methylphenethylaimine: |
|
4-34 |
paramethoxyamphetamine:PMA |
|
5-1 |
     (22) Ethylamine analog of phencyclidine.N-ethyl-1-phenylcyclohexylamine,;- |
|
5-2 |
phenylcyclohexyl) ethylamine, N-(1-phenylcyclophexyl) ethylamine, cyclohexamine,PCE |
|
5-3 |
     (23) Pyrrolidine analog of phencyclidine. 1-(1-phencyclohexyl)- pyrrolidine PCPy, |
|
5-4 |
PHP(24) Parahexyl; some trade or other names: 3-Hexyl-1-hydroxy-7,8,9,10-tetrahydro-,6,9- |
|
5-5 |
trimethyl-6H-dibenz o (b,d) pyran: Synhexyl. |
|
5-6 |
     (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any |
|
5-7 |
material, compound, mixture, or preparation which contains any quantity of the following |
|
5-8 |
substances having a depressant effect on the central nervous system, including its salts, isomers, |
|
5-9 |
and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible |
|
5-10 |
within the specific chemical designation: |
|
5-11 |
      (1) Mecloqualone. |
|
5-12 |
      (2) Methaqualone. |
|
5-13 |
      (3) 3-methyl fentanyl (n-( ethyl-1(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide. |
|
5-14 |
      (4) 3,4-methyl-enedioxymethamphetamine (MDMA), its optical, positional and |
|
5-15 |
geometric isomers, salts, and salts of isomers. |
|
5-16 |
      (5) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP), its optical isomers, salts and |
|
5-17 |
salts of isomers. |
|
5-18 |
      (6) 1-(2-phenylethyl)-4-phenyl-4-acetyloxypiperidine (PEPAP), its optical isomers, salts |
|
5-19 |
and salts of isomers. |
|
5-20 |
      (7) N-(1-(1-methyl-2-phenyl)ethyl-4-piperidyl)-N-phenyl-acetamide (acetyl-alpha- |
|
5-21 |
methylfentanyl), its optical isomers, salts and salts of isomers. |
|
5-22 |
      (8) N-(1-(1-methyl-2(2-thienyl)ethyl-4-piperidyl)-N-phenylpropanami de (alpha- |
|
5-23 |
methylthiofentanyl), its optical isomers, salts and salts of isomers. |
|
5-24 |
      (9) N-(1-benzyl-piperidyl)-N-phenylpropanamide (benzyl-fentanyl), its optical isomers, |
|
5-25 |
salts and salts of isomers. |
|
5-26 |
      (10) N-(1-(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenyl-propanamid e (beta- |
|
5-27 |
hydroxyfentanyl), its optical isomers, salts and salts of isomers. |
|
5-28 |
      (11) N-(3-methyl-1(2-hydroxy-2-phenyl)ethyl-4-piperidyl)-N-phenylpro panamide (beta- |
|
5-29 |
hydroxy-3-methylfentanyl), its optical and geometric isomers, salts and salts of isomers. |
|
5-30 |
      (12) N-(3-methyl)-1-(2-(2-thienyl)ethyl-4-piperidyl)-N-phenylpro- panamide (3- |
|
5-31 |
methylthiofentanyl), its optical and geometric isomers, salts and salts of isomers. |
|
5-32 |
      (13) N-(1-2-thienyl)methyl-4-piperidyl)-N-phenylpropanamide (thenylfentanyl), its |
|
5-33 |
optical isomers, salts and salts of isomers. |
|
6-34 |
      (14) N-(1-(2(2-thienyl)ethyl-4-piperidyl-N-phenylpropanamide (thiofentanyl), its optical |
|
6-35 |
isomers, salts and salts of isomers. |
|
6-36 |
      (15) N-[1-(2-phenylethyl)-4-piperidyl]N-(4-fluorophenyl)-propanamid e (para- |
|
6-37 |
fluorofentanyl), its optical isomers, salts and salts of isomers. |
|
6-38 |
      (16) Gamma hydroxybutyrate, HOOC-CH2-CH2-CH2OH, its optical, position, or |
|
6-39 |
geometric isomers, salts and salts of isomers. |
|
6-40 |
      (f) Stimulants. - Unless specifically excepted or unless listed in another schedule, any |
|
6-41 |
material, compound, mixture, or preparation which contains any quantity of the following |
|
6-42 |
substances having a stimulant effect on the central nervous system, including its salts, isomers, |
|
6-43 |
and salts of isomers: |
|
6-44 |
      (1) Fenethylline |
|
6-45 |
      (2) N-ethylamphetamine |
|
6-46 |
      (3) Methylenedioxymethcathinone (Methylone) |
|
6-47 |
      (4) Methylenedioxypyrovalerone (MDPV) |
|
6-48 |
      (5) Methylmethcathinone (Mephedrone) |
|
6-49 |
      (6) Methoxymethcathinone |
|
6-50 |
      (7) Fluoromethcathinone |
|
6-51 |
      Schedule II |
|
6-52 |
      (a) Schedule II shall consist of the drugs and other substances, by whatever official |
|
6-53 |
name, common or usual name, chemical name, or brand name designated, listed in this section. |
|
6-54 |
      (b) Substances, vegetable origin or chemical synthesis. - Unless specifically excepted or |
|
6-55 |
unless listed in another schedule, any of the following substances whether produced directly or |
|
6-56 |
indirectly by extraction from substances of vegetable origin, or independently by means of |
|
6-57 |
chemical synthesis, or by a combination of extraction and chemical synthesis: |
|
6-58 |
      (1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or |
|
6-59 |
opiate excluding naloxone and its salts, and excluding naltrexone and its salts, but including the |
|
6-60 |
following: |
|
6-61 |
      (i) Raw opium |
|
6-62 |
      (ii) Opium extracts |
|
6-63 |
      (iii) Opium fluid extracts |
|
6-64 |
      (iv) Powdered opium |
|
6-65 |
      (v) Granulated opium |
|
6-66 |
      (vi) Tincture of opium |
|
6-67 |
      (vii) Etorphine hydrochloride |
|
7-68 |
      (viii) Codeine |
|
7-69 |
      (ix) Ethylmorphine |
|
7-70 |
      (x) Hydrocodone |
|
7-71 |
      (xi) Hydromorphone |
|
7-72 |
      (xii) Metopon |
|
7-73 |
      (xiii) Morphine |
|
7-74 |
      (xiv) Oxycodone |
|
7-75 |
      (xv) Oxymorphone |
|
7-76 |
      (xvi) Thebaine |
|
7-77 |
      (2) Any salt, compound, derivative, or preparation which is chemically equivalent or |
|
7-78 |
identical with any of the substances referred to in subdivision (1) of this subsection, except that |
|
7-79 |
these substances shall not include the isoquinoline alkaloids of opium. |
|
7-80 |
      (3) Opium poppy and poppy straw. |
|
7-81 |
      (4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and |
|
7-82 |
any salt, compound, derivative, or preparation which is chemically equivalent or identical with |
|
7-83 |
any of these substances, except that the substances shall not include decocainized coca leaves or |
|
7-84 |
extraction of coca leaves, which extractions do not contain cocaine or ecgonine. |
|
7-85 |
      (5) Concentrate of poppy straw (the crude extract of poppy straw in liquid, solid, or |
|
7-86 |
powder form which contains the phenanthrine alkaloids of the opium poppy). |
|
7-87 |
      (c) Opiates. - Unless specifically excepted or unless listed in another schedule any of the |
|
7-88 |
following opiates, including its isomers, esters, ethers, salts; and salts of isomers, esters and, |
|
7-89 |
ethers whenever the existence of the isomers, esters, ethers, and salts is possible within the |
|
7-90 |
specific chemical designation: |
|
7-91 |
      (1) Alphaprodine |
|
7-92 |
      (2) Anileridine |
|
7-93 |
      (3) Bezitramide |
|
7-94 |
      (4) Dihydrocodeine |
|
7-95 |
      (5) Diphenoxylate |
|
7-96 |
      (6) Fentanyl |
|
7-97 |
      (7) Isomethadone |
|
7-98 |
      (8) Levomethorphan |
|
7-99 |
      (9) Levorphanol |
|
7-100 |
      (10) Metazocine |
|
7-101 |
      (11) Methadone |
|
8-102 |
      (12) Methadone-Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane |
|
8-103 |
      (13) Moramide-Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic |
|
8-104 |
acid |
|
8-105 |
      (14) Pethidine |
|
8-106 |
      (15) Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenylpiperidine |
|
8-107 |
      (16) Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate |
|
8-108 |
      (17) Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid |
|
8-109 |
      (18) Phenaxocine |
|
8-110 |
      (19) Piminodine |
|
8-111 |
      (20) Racemethorphan |
|
8-112 |
      (21) Racemorphan |
|
8-113 |
      (22) Bulk Dextropropoxyphene (non-dosage forms) |
|
8-114 |
      (23) Suffentanil |
|
8-115 |
      (24) Alfentanil |
|
8-116 |
      (25) Levoalphacetylmethadol |
|
8-117 |
      (d) Stimulants. - Unless specifically excepted or unless listed in another schedule, any |
|
8-118 |
material, compound, mixture, or preparation which contains any quantity of the following |
|
8-119 |
substances having a stimulant effect on the central nervous system: |
|
8-120 |
      (1) Amphetamine, its salts, optical isomers, and salts of its optical isomers. |
|
8-121 |
      (2) Methamphetamine, its salts and salts of its isomers. |
|
8-122 |
      (3) Phenmetrazine and its salts. |
|
8-123 |
      (4) Methylphenidate. |
|
8-124 |
      (e) Depressants. - Unless specifically excepted or unless listed in another schedule, any |
|
8-125 |
material, compound, mixture, or preparation which contains any quantity of the following |
|
8-126 |
substances having a depressant effect on the central nervous system, including its salts, isomers, |
|
8-127 |
and salts of isomers whenever the existence of the salts, isomers, and salts of isomers is possible |
|
8-128 |
within the specific chemical designation: |
|
8-129 |
      (1) Amobarbital |
|
8-130 |
      (2) Glutethimide |
|
8-131 |
      (3) Methyprylon |
|
8-132 |
      (4) Pentobarbital |
|
8-133 |
      (5) Phencyclidine |
|
8-134 |
      (6) Secobarbital |
|
8-135 |
      (7) Phencyclidine immediate precursors: |
|
9-136 |
      (i) 1-phencyclohexylamine |
|
9-137 |
      (ii) 1-piperidinocyclohexane-carbonitrile (PCC) |
|
9-138 |
      (8) Immediate precursor to amphetamine and methamphetamine: Phenylacetone. Some |
|
9-139 |
other names: phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzone ketone. |
|
9-140 |
      Schedule III |
|
9-141 |
      (a) Unless specifically excepted or unless listed in another schedule, any material, |
|
9-142 |
compound, mixture, or preparation which contains any quantity of the following substances |
|
9-143 |
having a depressant effect on the central nervous system: |
|
9-144 |
      (1) Any substance which contains any quantity of a derivative of barbituric acid, or any |
|
9-145 |
salt of a derivative of barbituric acid. |
|
9-146 |
      (2) Chlorhexadol |
|
9-147 |
      (3) Lysergic acid |
|
9-148 |
      (4) Lysergic acid amide |
|
9-149 |
      (5) Sulfondiethylmethane |
|
9-150 |
      (6) Sulfonethylmethane |
|
9-151 |
      (7) Sylfonmethane |
|
9-152 |
      (8) Any compound, mixture, or preparation containing amobarbital, secobarbital, |
|
9-153 |
pentobarbital, or any salt of them and one or more other active medicinal ingredients which are |
|
9-154 |
not listed in any schedule. |
|
9-155 |
      (9) Any suppository dosage form containing amobarbital, secobarbital, pentobarbital or |
|
9-156 |
any salt of any of these drugs and approved by the Food and Drug Administration for marketing |
|
9-157 |
only as a suppository. |
|
9-158 |
      (10) Ketamine, its salts, isomers and salts of isomers. (Some other names for ketamine: |
|
9-159 |
(+)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone). |
|
9-160 |
      (b) Unless specifically excepted or unless listed in another schedule, any material, |
|
9-161 |
compound, mixture, or preparation containing limited quantities of any of the following narcotic |
|
9-162 |
drugs, or any salts of them: |
|
9-163 |
      (1) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred |
|
9-164 |
milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with an equal |
|
9-165 |
or greater quantity of an isoquinoline alkaloid of opium. |
|
9-166 |
      (2) Not more than one and eight tenths grams (1.8 gms.) of codeine per one hundred |
|
9-167 |
milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with one or |
|
9-168 |
more active, nonnarcotic ingredients in recognized therapeutic amounts. |
|
9-169 |
      (3) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one |
|
9-170 |
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with |
|
10-1 |
a fourfold or greater quantity of an isoquinoline alkaloid of opium. |
|
10-2 |
      (4) Not more than three hundred milligrams (300 mgs.) of dihydrocodeinone per one |
|
10-3 |
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with |
|
10-4 |
one or more active nonnarcotic ingredients in recognized therapeutic amounts. |
|
10-5 |
      (5) Not more than one and eight tenths grams (1.8 gms.) of dihydrocodeine per one |
|
10-6 |
hundred milliliters (100 mls.) or not more than ninety milligrams (90 mgs.) per dosage unit, with |
|
10-7 |
one or more active nonnarcotic ingredients in recognized therapeutic amounts. |
|
10-8 |
      (6) Not more than three hundred milligrams (300 mgs.) of ethylmorphine per one |
|
10-9 |
hundred milliliters (100 mls.) or not more than fifteen milligrams (15 mgs.) per dosage unit, with |
|
10-10 |
one or more active nonnarcotic ingredients in recognized therapeutic amounts. |
|
10-11 |
      (7) Not more than five hundred milligrams (500 mgs.) of opium per one hundred |
|
10-12 |
milliliters (100 mls.) or per one hundred grams (100 gms.) or not more than twenty-five |
|
10-13 |
milligrams (25 mgs.) per dosage unit, with one or more active nonnarcotic ingredients in |
|
10-14 |
recognized therapeutic amounts. |
|
10-15 |
      (8) Not more than fifty milligrams (50 mgs.) of morphine per one hundred milliliters |
|
10-16 |
(100 mls.) per one hundred grams (100 gms.) with one or more active, nonnarcotic ingredients in |
|
10-17 |
recognized therapeutic amounts. |
|
10-18 |
      (c) Stimulants. - Unless specifically excepted or listed in another schedule, any material, |
|
10-19 |
compound, mixture, or preparation which contains any quantity of the following substances |
|
10-20 |
having a stimulant effect on the central nervous system, including its salts, isomers, and salts of |
|
10-21 |
the isomers whenever the existence of the salts of isomers is possible within the specific chemical |
|
10-22 |
designation: |
|
10-23 |
      (1) Benzphetamine |
|
10-24 |
      (2) Chlorphentermine |
|
10-25 |
      (3) Clortermine |
|
10-26 |
      (4) Mazindol |
|
10-27 |
      (5) Phendimetrazine |
|
10-28 |
      (d) Steroids and hormones. - Anabolic steroids (AS) or human growth hormone (HGH), |
|
10-29 |
excluding those compounds, mixtures, or preparations containing an anabolic steroid that because |
|
10-30 |
of its concentration, preparation, mixture or delivery system, has no significant potential for |
|
10-31 |
abuse, as published in 21 CFR 1308.34, including, but not limited to, the following: |
|
10-32 |
      (1) Chlorionic gonadotropin |
|
10-33 |
      (2) Clostebol |
|
11-34 |
      (3) Dehydrochlormethyltestosterone |
|
11-35 |
      (4) Ethylestrenol |
|
11-36 |
      (5) Fluoxymesterone |
|
11-37 |
      (6) Mesterolone |
|
11-38 |
      (7) Metenolone |
|
11-39 |
      (8) Methandienone |
|
11-40 |
      (9) Methandrostenolone |
|
11-41 |
      (10) Methyltestosterone |
|
11-42 |
      (11) Nandrolone decanoate |
|
11-43 |
      (12) Nandrolone phenpropionate |
|
11-44 |
      (13) Norethandrolone |
|
11-45 |
      (14) Oxandrolone |
|
11-46 |
      (15) Oxymesterone |
|
11-47 |
      (16) Oxymetholone |
|
11-48 |
      (17) Stanozolol |
|
11-49 |
      (18) Testosterone propionate |
|
11-50 |
      (19) Testosterone-like related compounds |
|
11-51 |
      (20) Human Growth Hormone (HGH) |
|
11-52 |
      (e) Hallucinogenic substances. |
|
11-53 |
      (1) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in |
|
11-54 |
U.S. Food and Drug Administration approved drug product. (Some other names for dronabinol: |
|
11-55 |
(6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9- trimethyl-3-pentyl-6H- dibenzo[b,d]yra n-1-ol,or(-)- |
|
11-56 |
delta-9(trans)-tetrahydrocannabinol.) |
|
11-57 |
      Schedule IV |
|
11-58 |
      (1) Barbital. |
|
11-59 |
      (2) Chloral betaine |
|
11-60 |
      (3) Chloral hydrate |
|
11-61 |
      (4) Ethchrovynol |
|
11-62 |
      (5) Ethinamate |
|
11-63 |
      (6) Methohexital |
|
11-64 |
      (7) Meprobamate |
|
11-65 |
      (8) Methylphenobarbital |
|
11-66 |
      (9) Paraldehyde |
|
11-67 |
      (10) Petrichloral |
|
12-68 |
      (11) Phenobarbital |
|
12-69 |
      (12) Fenfluramine |
|
12-70 |
      (13) Diethylpropion |
|
12-71 |
      (14) Phentermine |
|
12-72 |
      (15) Pemoline (including organometallic complexes and chelates thereof). |
|
12-73 |
      (16) Chlordiazepoxide |
|
12-74 |
      (17) Clonazepam |
|
12-75 |
      (18) Clorazepate |
|
12-76 |
      (19) Diazepam |
|
12-77 |
      (20) Flurazepam |
|
12-78 |
      (21) Mebutamate |
|
12-79 |
      (22) Oxazepam |
|
12-80 |
      (23) Unless specifically excepted or unless listed in another schedule, any material, |
|
12-81 |
compound, mixture, or preparation which contains any quantity of the following substances, |
|
12-82 |
including its salts: |
|
12-83 |
      Dextropropoxyphene(alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2- |
|
12-84 |
propronoxybutane). |
|
12-85 |
      (24) Prazepam |
|
12-86 |
      (25) Lorazepam |
|
12-87 |
      (26) Not more than one milligram (1 mg.) of difenoxin and not less than twenty-five (25) |
|
12-88 |
micrograms of atropine sulfate per dosage unit. |
|
12-89 |
      (27) Pentazocine |
|
12-90 |
      (28) Pipradrol |
|
12-91 |
      (29) SPA (-)-1-dimethylamino-1, 2-diphenylethane |
|
12-92 |
      (30) Temazepam |
|
12-93 |
      (31) Halazepam |
|
12-94 |
      (32) Alprazolam |
|
12-95 |
      (33) Bromazepam |
|
12-96 |
      (34) Camazepam |
|
12-97 |
      (35) Clobazam |
|
12-98 |
      (36) Clotiazepam |
|
12-99 |
      (37) Cloxazolam |
|
12-100 |
      (38) Delorazepam |
|
12-101 |
      (39) Estazolam |
|
13-102 |
      (40) Ethyl Ioflazepate |
|
13-103 |
      (41) Fludizaepam |
|
13-104 |
      (42) Flunitrazepam |
|
13-105 |
      (43) Haloxazolam |
|
13-106 |
      (44) Ketazolam |
|
13-107 |
      (45) Loprazolam |
|
13-108 |
      (46) Lormetazepam |
|
13-109 |
      (47) Medazepam |
|
13-110 |
      (48) Nimetazepam |
|
13-111 |
      (49) Nitrazepam |
|
13-112 |
      (50) Nordiazepam |
|
13-113 |
      (51) Oxazolam |
|
13-114 |
      (52) Pinazepam |
|
13-115 |
      (53) Tetrazepam |
|
13-116 |
      (54) Mazindol |
|
13-117 |
      (55) Triazolam |
|
13-118 |
      (56) Midazolam |
|
13-119 |
      (57) Quazepam |
|
13-120 |
      (58) Butorphanol |
|
13-121 |
      (59) Sibutramine |
|
13-122 |
      Schedule V |
|
13-123 |
      (a) Any compound, mixture, or preparation containing any of the following limited |
|
13-124 |
quantities of narcotic drugs, which shall include one or more non-narcotic active medicinal |
|
13-125 |
ingredients in sufficient proportion to confer upon the compound, mixture, or preparation |
|
13-126 |
valuable medicinal qualities other than those possessed by the narcotic drug alone: |
|
13-127 |
      (1) Not more than two hundred milligrams (200 mgs.) of codeine per 100 milliliters (100 |
|
13-128 |
mls.) or per one hundred grams (100 gms.). |
|
13-129 |
      (2) Not more than one hundred milligrams (100 mgs.) of dihydrocodeine per 100 |
|
13-130 |
milliliters (100 mls.) or per one hundred grams (100 gms.). |
|
13-131 |
      (3) Not more than one hundred milligrams (100 mgs.) of ethylmorphine per 100 |
|
13-132 |
milliliters (100 mls.) or per one hundred grams (100 gms.). |
|
13-133 |
      (4) Not more than two and five tenths milligrams (2.5 mgs.) of diphenixylate and not less |
|
13-134 |
than twenty-five (25) micrograms of atropine sulfate per dosage unit. |
|
13-135 |
      (5) Not more than one hundred milligrams (100 mgs.) of opium per one hundred |
|
13-136 |
milliliters (100 mls.) or per one hundred grams (100 gms.). |
|
14-1 |
      (b) Not more than five tenths milligrams (0.5 mgs.) of difenoxin and not less than |
|
14-2 |
twenty-five (25) micrograms of atropine sulfate per dosage unit. |
|
14-3 |
      (c) Buprenorphine |
|
14-4 |
      (d) Unless specifically exempted or excluded or unless listed in another schedule, any |
|
14-5 |
material, compound, mixture, or preparation which contains any quantity of the following |
|
14-6 |
substances having a stimulant effect on the central nervous system, including its salts, isomers |
|
14-7 |
and salts of isomers: |
|
14-8 |
      (1) Propylhexedrine (except as benzedrex inhaler) |
|
14-9 |
      (2) Pyrovalerone. |
|
14-10 |
     SECTION 2. This act shall take effect upon passage. |
|
      | |
|
======= | |
|
LC00395 | |
|
======== | |
|
EXPLANATION | |
|
BY THE LEGISLATIVE COUNCIL | |
|
OF | |
|
A N A C T | |
|
RELATING TO FOOD AND DRUGS - UNIFORM CONTROLLED SUBSTANCES ACT | |
|
*** | |
|
15-1 |
     This act would place Methylone, MDPV, Mephedrone and other compounds commonly |
|
15-2 |
known and marketed as "bath salts", on Schedule 1 of the Uniform Controlled Substances Act. |
|
15-3 |
     This act would take effect upon passage. |
|
      | |
|
======= | |
|
LC00395 | |
|
======= |